The effects of a high-fat meal on single-dose vemurafenib pharmacokinetics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effects of a high-fat meal on single-dose vemurafenib pharmacokinetics

Published:2014-01-22 Issue:4 Volume:54 Page:368-374
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Ribas Antoni¹,Zhang Weijiang²,Chang Ilsung³,Shirai Keisuke⁴,Ernstoff Marc S.⁵,Daud Adil⁶,Cowey C. Lance⁷,Daniels Gregory⁸,Seja Elizabeth¹,O'Laco Elizabeth¹,Glaspy John A.¹,Chmielowski Bartosz¹,Hill Todd²,Joe Andrew K.²,Grippo Joseph F.²

Affiliation:

1. Jonsson Comprehensive Cancer Center; University of California; Los Angeles CA USA

2. F. Hoffman-La Roche; Nutley NJ USA

3. Genentech, Inc.; South San Francisco CA USA

4. Medical University of South Carolina; Charleston SC USA

5. Dartmouth Hitchcock Medical Center; Norris Cotton Cancer Center; Lebanon NH USA

6. University of California; San Francisco CA USA

7. Texas Oncology-Baylor Charles A. Sammons Cancer Center; Dallas TX USA

8. University of California, San Diego; La Jolla CA USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference11 articles.

1. Mutations of the BRAF gene in human cancer;Davies;Nature.,2002

2. Melanoma biology and new targeted therapy;Gray-Schopfer;Nature.,2007

3. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma;Bollag;Nature.,2010

4. Inhibition of mutated, activated BRAF in metastatic melanoma;Flaherty;N Engl J Med.,2010

5. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib;Sosman;N Engl J Med.,2012

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictability of human exposure by human‐CYP3A4‐transgenic mouse models: A meta‐analysis;Clinical and Translational Science;2023-12

2. Drug-drug interaction potentials of tucatinib inhibition of human UDP-glucuronosyltransferases;Chemico-Biological Interactions;2023-08

3. Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects;Drug Design, Development and Therapy;2023-03

4. Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs;ESMO Open;2023-02

5. Effects of food and race on the pharmacokinetics of lazertinib in healthy subjects and patients with EGFR mutation-positive advanced non-small cell lung cancer;Lung Cancer;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3